Pérez-Sotelo LS, Talavera-Rojas M, Monroy-Salazar HG, Lagunas-Bernabé S, Cuarón-Ibargüengoytia JA, Montes de Oca JR, Vázquez-Chagoyán JC

Idioma: Ingles.
Referencias bibliográficas: 34
Paginas: 70-75
Archivo PDF: 109.64 Kb.

RESUMEN

La cepa Sc47 (Biosaf^TM) de Saccharomyces cerevisiae, es una levadura de panadería bajo patente industrial (Lesaffre, Francia), que ha sido usada como probiótico en la alimentación animal. Se ha observado que los animales que reciben esta levadura en la dieta tienen una mayor resistencia a diversas enfermedades infecciosas. Algunas cepas de S. cerevisiae adhieren bacterias potencialmente patógenas como Escherichia coli y Salmonella spp a su pared. Lo anterior sugiere un posible mecanismo por el cual los animales que consumen la levadura presentan una mayor resistencia a estas infecciones. En el presente estudio, se evaluó la adherencia de 45 aislamientos de Salmonella spp. a la cepa de S. cerevisiae Sc47 mediante pruebas de aglutinación, sedimentación, y de microscopia óptica y electrónica. Los resultados obtenidos mostraron que el 57.7% (26/45) de los aislamientos de Salmonella spp. y el 66.6% (6/9) de sus serovares mostraron adherencia a la levadura en cuestión.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Althouse, C., S. Patterson, P. Fedorka-Cray & R.E. Isaacson. 2003. Type 1 fimbriae of Salmonella enterica serovar typhimurium bind to enterocytes and contribute to colonization of swine in vivo. Infect. Immun. 71:6446-6452.

2. Blackburn, C.D. & A.R. Davies. 1994. Development of antibiotic-resistant strains for the enumeration of foodborne pathogenic bacteria in stored foods. Int. J Food Microbiol. 24:125-136.

3. Berthelot, F., C. Beumont, F. Mompart, O. Girdad-Santosuosso, P. Pardon & M.D. Shaux. 1998. Estimated heritability of the resistance to cecal carrier state of Salmonella enteritidis in chickens. Poult. Sci. 77:797-801.

4. Czerucka, D. & P. Rampal. 1999. Effect of Saccharomyces boulardii on cAMP. and Ca2+-dependent Cl-secretion in T84 cells. Dig Dis Sci. 44:2359-2369.

5. Czerucka, D., I., Roux & P. Rampal. 1994. Saccharomyces boulardii inhibits secretagogue-mediated adenosine 3’, 5’-cyclic monophosphate induction in intestinal cells. Gastroenterology. 106:65-72.

6. Castagliuolo, I., M.F., Riegler, L., Valenick, J.T. LaMont & C. Pothoulakis. 1996. Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa. Infect. Immun. 67:302-307.

7. Cole, N.A., C.W., Purdy & D.P. Hutcheson. 1992. Influence of yeast culture on feeder calves and lambs. J Anim Sci. 70:1682-1690.

8. Chia, J.K., S.M., Chan & H. Goldstein. 1995. Baker’s yeast as adjunctive therapy for relapses of Clostridium difficile diarrhea. Clin Infect Dis. 20:1581.

9. Ducluzeau, R., & M. Bensaada. 1982. Comparative effect of a single or continuous administration of “Saccharomyces boulardii” on the establishment of various strains of “Candida” in the digestive tract of gnotobiotic mice. Ann Microbiol (Paris). 133:491-501.

10. Elmer, G.W. 2001. Probiotics: “living drugs”. Am J Health Syst Pharm. 58:1101-1109.

11. Firon, N., I. Ofek & N. Sharon. 1982. Interaction of mannose-containing oligosaccharides with the fimbrial lectin of Escherichia coli. Biochem Biophys Res Commun. 105:1426-1432.

12. Gedek, B.R. 1999. Adherence of Escherichia coli serogroup O 157 and Salmonella typhimurium mutant DT 104 to the surface of Saccharomyces boulardii. Mycoses. 42:261-264.

13. Hayat, M.A. 2000. Electron microscopy. Fourth ed. Press Syndicate of University of Cambridge (U.K.).

14. Jurgens, M.H., R.A. Rikabi & D.R. Zimmerman. 1997. The effect of dietary active dry yeast supplement on performance of sows during gestation-lactation and their pigs. J Anim Sci. 75:593-597.

15. Korhonen, T.K., H. Leffler & C.S. Eden. 1981. Binding specificity of piliated strains of Escherichia coli and Salmonella typhymurium to epithelial cells, Saccharomyces cerevisiae cells and erythrocytes. Infect. Immun. 32:796-804.

16. Marteau, P.R., M. Vrese, C.J. Séller & J. Schrezenmeir. 2001. Protection from gastrointestinal diseases with the use of probiotics. Clin Nutr. 73(2 suppl):430S-436S.

17. Mathew, A.G., W.G. Upchurch & S.E. Chattin. 1998. Incidence of antibiotic resistance in fecal Escherichia coli isolated from commercial swine farms. J Anim Sci. 76:429-434.

18. McDermid, A.S, A.S. McKee, A.B. Dowset & P.D. Marsh. 1996. The effect of environmental pH on the physiology and surface structures of Salmonella serotype enteritidis phage type 4. J Med Microbiol. 6:452-458.

19. Normark, S., M. Baga & M. Goransson et al. 1986. Genetics and biogenesis of Escherichia coli adhesions. In Microbial lectines and agglutinins, ed. by Merelman, D. New York. Wiley & Sons. 113-143.

20. Pérez, V.G., Solorio, S., Martínez A., A., Castañeda-Silva, E., Cuarón, J.A. 2001. Saccharomyces cerevisiae for growing-finishing pigs in a septic environment. J. Anim. Sci. 84(Suppl. 1):454.

21. Qamar, A., S. Aboudola, M. Warny, P. Michetti, C. Pothoulakis, J.T. LaMont & C.P. Kelly. 2001. Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice. Infect. Immun. 2762-2765.

22. Ofek, I., D. Mirelman & N. Sharon. 1977. Adherence of Escherichia coli to human mucosal cells mediated by mannose receptors. Nature. 265:623-625.

23. Rodriguez, A.C., R.M. Nardi, E.A. Bambirra, E.C. Vieira & J.R. Nicoli. 1996. Effects of Saccharomyces boulardii against experimental oral infection with Samonella typhimurium and Shigella flexneri in conventional and gnotobiotic mice. J Appl Bacteriol. 81:251-256.

24. Roof BM., J. Roth, TT. Kramer. 1992. Porcine salmonellosis: characterization, immunity and potential vaccines. Compendium on Continuing Education for the practicing veterinarian. 14:411.

25. Schellenberg, D., A. Bonington, C.M Champion, R. Lancaster, S. Webb & J. Main. 1994. Treatment of Clostridium difficile diarrhoea with brewer’s yeast. Lancet 343:171-172.

26. Straw, E.B., D. Sylvie, M.L. William & D. J. Taylor. 1999. Disease of Swine, 8th edition, Iowa State University Press: Ames. pp. 535-551.

27. Shwartz, K.J. 1999. Salmonellosis. In: EB Straw, D. Sylvie, M.L. William & D.J. Taylor (Eds). Disease of Swine, 8th ed., Iowa State University Press: Ames, USA. pp. 535-551.

28. Tasteyre, A., M.C. Barc, T. Karjalainen, P. Bourlioux & A. Collignon. 2002. Inhibition of in vitro cell adherence of Clostridium difficile by Saccharomyces boulardii. Microb Pathog. 32:219-225.

29. Talavera, R.M. 2005. Análisis epidemiológico molecular de Salmonella spp. y su relación con la resistencia antibiótica en cerdos de abasto en rastros del Valle de Toluca, México. Tesis doctoral, Universidad de Colima, México.

30. Terrango, R., M.L. Caffer, S. Bruno & S. Binstein. 2003. Aislamiento, identificación y serotipificación Salmonella parte 1. En Manual de procedimientos Ministerio de Salud de la Secretaría de Políticas, Regulación y Relaciones Sanitarias, Administración Nacional de Laboratorios e Institutos de Salud “Dr. Carlos C. Malbran”. Buenos Aires, Argentina.

31. van Heuten, E., D.W. Funderburke & K.L. Dorton. 2003. Growth performance, nutrient digestibility, and fecal microflora in weanling pigs fed yeast. J Anim Sci. 81: 1004-1012.

32. Veum, T.L., J. Reyes & M. Ellersieck. 1995. Effect of supplemental yeast culture in sow gestation and lactation diets on apparent nutrient digestibility and reproductive performance through one reproductive cycle. J Anim Sci. 73:1741-1745.

33. Winokur P.L., Brueggmann A., DeSalvo D.L., Hoffmann L., Apley M.D., Uhlenhopp E.K., Pfaller M.A., & Doern G.V. 2000. Animal and human multidrug-resistant, cephalosporin-resistant Salmonella isolates expressing a plasmid-mediated CMY-2 AmpC b-Lactamase. Antimicrob Agents Chemother. 44:2777-2783.

34. Zhang, X.L, I.S. Tsui, C.M. Yip, A.W. Fung., D.K. Wong, X. Dai, Y. Yang, J. Hackett & Morris. 2000. Salmonella enterica serovar typhi uses type IVB pili to enter human intestinal epithelial cells. Infect Immun. 6:3067-3073.